In line with this regained importance of myc in MM pathogenesis, the interferon regulatory factor (IRF) 4, a direct target of c-myc activation, was recently identified among other oncogenic candidates to be indispensable for MM tumor growth, although sparsely involved in genetic alterations and translocations (25). Here, MYC is linked to neoplasm.